Influenza Vaccine Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Inactivated, Live Attenuated); Product Type (Trivalent Vaccine, Quadrivalent Vaccine); Dosage Form (Nasal Spray, Intramuscular Injection, Intradermal); Age Group (Pediatric, Adult); Distribution Channel (Hospital and Retail Pharmacies, Government Suppliers, Others), and Geography

Report Code: TIPRE00022593 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Influenza also referred to as the flu, is a viral infection that affects the respiratory system. Type A, Type B, and Type C are the three main influenza viruses that affect humans. Type D influenza virus, the fourth type, does not infect humans, although it is thought to have the potential to infect. Influenza vaccine protects against the influenza virus. Due to the rapid changes in the influenza virus, newer versions of influenza vaccines are developed twice a year. The efficacy of these vaccines varies from year to year, but they are known to provide moderate to high influenza protection.

MARKET DYNAMICS

Factors driving the growth of the influenza vaccine market are the increasing prevalence of Influenza, coupled with growing awareness campaigns and free vaccine. However, the high cost of associated with influenza vaccine is expected to hamper the growth of the market. Moreover, increase in the government initiatives promoting the administration of influenza vaccine and minimal side effects associated with the vaccine is anticipated to boost the market growth.

MARKET SCOPE

The "Influenza Vaccine Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of influenza vaccine market with detailed market segmentation by type, product type, dosage form, age group, and distribution channel. The influenza vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in influenza vaccine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The influenza vaccine market is segmented on the basis of type, product type, dosage form, age group, and distribution channel. Based on type, the market is segmented as inactivated and live attenuated. Based on product type, the market is segmented as trivalent vaccine and quadrivalent vaccine. On the basis of dosage form, the market is categorized as nasal spray, intramuscular injection, and intradermal. On the basis of age group, the market is categorized as pediatric and adult. On the basis of distribution channel, the market is categorized as hospital & retail pharmacies, government suppliers, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the influenza vaccine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The influenza vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting influenza vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the influenza vaccine market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the influenza vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from influenza vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for influenza vaccine in the global market. Below mentioned is the list of few companies engaged in the influenza vaccine market.

The report also includes the profiles of key players in influenza vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Emergent BioSolutions
  •   F. Hoffmann-La Roche Ltd
  •   Gamma Vaccines Pty Ltd.
  •   AstraZeneca Plc.
  •   Biodiem
  •   CSL Limited
  •   GlaxoSmithKline Plc.
  •   Merck & Co., Inc. (Merck Sharp & Dohme Corp.)
  •   Novartis AG

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Influenza Vaccine Market - By Type
1.3.2 Influenza Vaccine Market - By Product Type
1.3.3 Influenza Vaccine Market - By Dosage Form
1.3.4 Influenza Vaccine Market - By Age Group
1.3.5 Influenza Vaccine Market - By Distribution Channel
1.3.6 Influenza Vaccine Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFLUENZA VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFLUENZA VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFLUENZA VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. INFLUENZA VACCINE - GLOBAL MARKET OVERVIEW
6.2. INFLUENZA VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. INFLUENZA VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. INACTIVATED
7.3.1. Overview
7.3.2. Inactivated Market Forecast and Analysis
7.4. LIVE ATTENUATED
7.4.1. Overview
7.4.2. Live Attenuated Market Forecast and Analysis
8. INFLUENZA VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
8.1. OVERVIEW
8.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
8.3. TRIVALENT VACCINE
8.3.1. Overview
8.3.2. Trivalent Vaccine Market Forecast and Analysis
8.4. QUADRIVALENT VACCINE
8.4.1. Overview
8.4.2. Quadrivalent Vaccine Market Forecast and Analysis
9. INFLUENZA VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - DOSAGE FORM
9.1. OVERVIEW
9.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
9.3. NASAL SPRAY
9.3.1. Overview
9.3.2. Nasal Spray Market Forecast and Analysis
9.4. INTRAMUSCULAR INJECTION
9.4.1. Overview
9.4.2. Intramuscular Injection Market Forecast and Analysis
9.5. INTRADERMAL
9.5.1. Overview
9.5.2. Intradermal Market Forecast and Analysis
10. INFLUENZA VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - AGE GROUP
10.1. OVERVIEW
10.2. AGE GROUP MARKET FORECASTS AND ANALYSIS
10.3. PEDIATRIC
10.3.1. Overview
10.3.2. Pediatric Market Forecast and Analysis
10.4. ADULT
10.4.1. Overview
10.4.2. Adult Market Forecast and Analysis
11. INFLUENZA VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
11.1. OVERVIEW
11.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
11.3. HOSPITAL AND RETAIL PHARMACIES
11.3.1. Overview
11.3.2. Hospital and Retail Pharmacies Market Forecast and Analysis
11.4. GOVERNMENT SUPPLIERS
11.4.1. Overview
11.4.2. Government Suppliers Market Forecast and Analysis
11.5. OTHERS
11.5.1. Overview
11.5.2. Others Market Forecast and Analysis
12. INFLUENZA VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Influenza Vaccine Market Overview
12.1.2 North America Influenza Vaccine Market Forecasts and Analysis
12.1.3 North America Influenza Vaccine Market Forecasts and Analysis - By Type
12.1.4 North America Influenza Vaccine Market Forecasts and Analysis - By Product Type
12.1.5 North America Influenza Vaccine Market Forecasts and Analysis - By Dosage Form
12.1.6 North America Influenza Vaccine Market Forecasts and Analysis - By Age Group
12.1.7 North America Influenza Vaccine Market Forecasts and Analysis - By Distribution Channel
12.1.8 North America Influenza Vaccine Market Forecasts and Analysis - By Countries
12.1.8.1 United States Influenza Vaccine Market
12.1.8.1.1 United States Influenza Vaccine Market by Type
12.1.8.1.2 United States Influenza Vaccine Market by Product Type
12.1.8.1.3 United States Influenza Vaccine Market by Dosage Form
12.1.8.1.4 United States Influenza Vaccine Market by Age Group
12.1.8.1.5 United States Influenza Vaccine Market by Distribution Channel
12.1.8.2 Canada Influenza Vaccine Market
12.1.8.2.1 Canada Influenza Vaccine Market by Type
12.1.8.2.2 Canada Influenza Vaccine Market by Product Type
12.1.8.2.3 Canada Influenza Vaccine Market by Dosage Form
12.1.8.2.4 Canada Influenza Vaccine Market by Age Group
12.1.8.2.5 Canada Influenza Vaccine Market by Distribution Channel
12.1.8.3 Mexico Influenza Vaccine Market
12.1.8.3.1 Mexico Influenza Vaccine Market by Type
12.1.8.3.2 Mexico Influenza Vaccine Market by Product Type
12.1.8.3.3 Mexico Influenza Vaccine Market by Dosage Form
12.1.8.3.4 Mexico Influenza Vaccine Market by Age Group
12.1.8.3.5 Mexico Influenza Vaccine Market by Distribution Channel
12.2. EUROPE
12.2.1 Europe Influenza Vaccine Market Overview
12.2.2 Europe Influenza Vaccine Market Forecasts and Analysis
12.2.3 Europe Influenza Vaccine Market Forecasts and Analysis - By Type
12.2.4 Europe Influenza Vaccine Market Forecasts and Analysis - By Product Type
12.2.5 Europe Influenza Vaccine Market Forecasts and Analysis - By Dosage Form
12.2.6 Europe Influenza Vaccine Market Forecasts and Analysis - By Age Group
12.2.7 Europe Influenza Vaccine Market Forecasts and Analysis - By Distribution Channel
12.2.8 Europe Influenza Vaccine Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Influenza Vaccine Market
12.2.8.1.1 Germany Influenza Vaccine Market by Type
12.2.8.1.2 Germany Influenza Vaccine Market by Product Type
12.2.8.1.3 Germany Influenza Vaccine Market by Dosage Form
12.2.8.1.4 Germany Influenza Vaccine Market by Age Group
12.2.8.1.5 Germany Influenza Vaccine Market by Distribution Channel
12.2.8.2 France Influenza Vaccine Market
12.2.8.2.1 France Influenza Vaccine Market by Type
12.2.8.2.2 France Influenza Vaccine Market by Product Type
12.2.8.2.3 France Influenza Vaccine Market by Dosage Form
12.2.8.2.4 France Influenza Vaccine Market by Age Group
12.2.8.2.5 France Influenza Vaccine Market by Distribution Channel
12.2.8.3 Italy Influenza Vaccine Market
12.2.8.3.1 Italy Influenza Vaccine Market by Type
12.2.8.3.2 Italy Influenza Vaccine Market by Product Type
12.2.8.3.3 Italy Influenza Vaccine Market by Dosage Form
12.2.8.3.4 Italy Influenza Vaccine Market by Age Group
12.2.8.3.5 Italy Influenza Vaccine Market by Distribution Channel
12.2.8.4 Spain Influenza Vaccine Market
12.2.8.4.1 Spain Influenza Vaccine Market by Type
12.2.8.4.2 Spain Influenza Vaccine Market by Product Type
12.2.8.4.3 Spain Influenza Vaccine Market by Dosage Form
12.2.8.4.4 Spain Influenza Vaccine Market by Age Group
12.2.8.4.5 Spain Influenza Vaccine Market by Distribution Channel
12.2.8.5 United Kingdom Influenza Vaccine Market
12.2.8.5.1 United Kingdom Influenza Vaccine Market by Type
12.2.8.5.2 United Kingdom Influenza Vaccine Market by Product Type
12.2.8.5.3 United Kingdom Influenza Vaccine Market by Dosage Form
12.2.8.5.4 United Kingdom Influenza Vaccine Market by Age Group
12.2.8.5.5 United Kingdom Influenza Vaccine Market by Distribution Channel
12.2.8.6 Rest of Europe Influenza Vaccine Market
12.2.8.6.1 Rest of Europe Influenza Vaccine Market by Type
12.2.8.6.2 Rest of Europe Influenza Vaccine Market by Product Type
12.2.8.6.3 Rest of Europe Influenza Vaccine Market by Dosage Form
12.2.8.6.4 Rest of Europe Influenza Vaccine Market by Age Group
12.2.8.6.5 Rest of Europe Influenza Vaccine Market by Distribution Channel
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Influenza Vaccine Market Overview
12.3.2 Asia-Pacific Influenza Vaccine Market Forecasts and Analysis
12.3.3 Asia-Pacific Influenza Vaccine Market Forecasts and Analysis - By Type
12.3.4 Asia-Pacific Influenza Vaccine Market Forecasts and Analysis - By Product Type
12.3.5 Asia-Pacific Influenza Vaccine Market Forecasts and Analysis - By Dosage Form
12.3.6 Asia-Pacific Influenza Vaccine Market Forecasts and Analysis - By Age Group
12.3.7 Asia-Pacific Influenza Vaccine Market Forecasts and Analysis - By Distribution Channel
12.3.8 Asia-Pacific Influenza Vaccine Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Influenza Vaccine Market
12.3.8.1.1 Australia Influenza Vaccine Market by Type
12.3.8.1.2 Australia Influenza Vaccine Market by Product Type
12.3.8.1.3 Australia Influenza Vaccine Market by Dosage Form
12.3.8.1.4 Australia Influenza Vaccine Market by Age Group
12.3.8.1.5 Australia Influenza Vaccine Market by Distribution Channel
12.3.8.2 China Influenza Vaccine Market
12.3.8.2.1 China Influenza Vaccine Market by Type
12.3.8.2.2 China Influenza Vaccine Market by Product Type
12.3.8.2.3 China Influenza Vaccine Market by Dosage Form
12.3.8.2.4 China Influenza Vaccine Market by Age Group
12.3.8.2.5 China Influenza Vaccine Market by Distribution Channel
12.3.8.3 India Influenza Vaccine Market
12.3.8.3.1 India Influenza Vaccine Market by Type
12.3.8.3.2 India Influenza Vaccine Market by Product Type
12.3.8.3.3 India Influenza Vaccine Market by Dosage Form
12.3.8.3.4 India Influenza Vaccine Market by Age Group
12.3.8.3.5 India Influenza Vaccine Market by Distribution Channel
12.3.8.4 Japan Influenza Vaccine Market
12.3.8.4.1 Japan Influenza Vaccine Market by Type
12.3.8.4.2 Japan Influenza Vaccine Market by Product Type
12.3.8.4.3 Japan Influenza Vaccine Market by Dosage Form
12.3.8.4.4 Japan Influenza Vaccine Market by Age Group
12.3.8.4.5 Japan Influenza Vaccine Market by Distribution Channel
12.3.8.5 South Korea Influenza Vaccine Market
12.3.8.5.1 South Korea Influenza Vaccine Market by Type
12.3.8.5.2 South Korea Influenza Vaccine Market by Product Type
12.3.8.5.3 South Korea Influenza Vaccine Market by Dosage Form
12.3.8.5.4 South Korea Influenza Vaccine Market by Age Group
12.3.8.5.5 South Korea Influenza Vaccine Market by Distribution Channel
12.3.8.6 Rest of Asia-Pacific Influenza Vaccine Market
12.3.8.6.1 Rest of Asia-Pacific Influenza Vaccine Market by Type
12.3.8.6.2 Rest of Asia-Pacific Influenza Vaccine Market by Product Type
12.3.8.6.3 Rest of Asia-Pacific Influenza Vaccine Market by Dosage Form
12.3.8.6.4 Rest of Asia-Pacific Influenza Vaccine Market by Age Group
12.3.8.6.5 Rest of Asia-Pacific Influenza Vaccine Market by Distribution Channel
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Influenza Vaccine Market Overview
12.4.2 Middle East and Africa Influenza Vaccine Market Forecasts and Analysis
12.4.3 Middle East and Africa Influenza Vaccine Market Forecasts and Analysis - By Type
12.4.4 Middle East and Africa Influenza Vaccine Market Forecasts and Analysis - By Product Type
12.4.5 Middle East and Africa Influenza Vaccine Market Forecasts and Analysis - By Dosage Form
12.4.6 Middle East and Africa Influenza Vaccine Market Forecasts and Analysis - By Age Group
12.4.7 Middle East and Africa Influenza Vaccine Market Forecasts and Analysis - By Distribution Channel
12.4.8 Middle East and Africa Influenza Vaccine Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Influenza Vaccine Market
12.4.8.1.1 South Africa Influenza Vaccine Market by Type
12.4.8.1.2 South Africa Influenza Vaccine Market by Product Type
12.4.8.1.3 South Africa Influenza Vaccine Market by Dosage Form
12.4.8.1.4 South Africa Influenza Vaccine Market by Age Group
12.4.8.1.5 South Africa Influenza Vaccine Market by Distribution Channel
12.4.8.2 Saudi Arabia Influenza Vaccine Market
12.4.8.2.1 Saudi Arabia Influenza Vaccine Market by Type
12.4.8.2.2 Saudi Arabia Influenza Vaccine Market by Product Type
12.4.8.2.3 Saudi Arabia Influenza Vaccine Market by Dosage Form
12.4.8.2.4 Saudi Arabia Influenza Vaccine Market by Age Group
12.4.8.2.5 Saudi Arabia Influenza Vaccine Market by Distribution Channel
12.4.8.3 U.A.E Influenza Vaccine Market
12.4.8.3.1 U.A.E Influenza Vaccine Market by Type
12.4.8.3.2 U.A.E Influenza Vaccine Market by Product Type
12.4.8.3.3 U.A.E Influenza Vaccine Market by Dosage Form
12.4.8.3.4 U.A.E Influenza Vaccine Market by Age Group
12.4.8.3.5 U.A.E Influenza Vaccine Market by Distribution Channel
12.4.8.4 Rest of Middle East and Africa Influenza Vaccine Market
12.4.8.4.1 Rest of Middle East and Africa Influenza Vaccine Market by Type
12.4.8.4.2 Rest of Middle East and Africa Influenza Vaccine Market by Product Type
12.4.8.4.3 Rest of Middle East and Africa Influenza Vaccine Market by Dosage Form
12.4.8.4.4 Rest of Middle East and Africa Influenza Vaccine Market by Age Group
12.4.8.4.5 Rest of Middle East and Africa Influenza Vaccine Market by Distribution Channel
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Influenza Vaccine Market Overview
12.5.2 South and Central America Influenza Vaccine Market Forecasts and Analysis
12.5.3 South and Central America Influenza Vaccine Market Forecasts and Analysis - By Type
12.5.4 South and Central America Influenza Vaccine Market Forecasts and Analysis - By Product Type
12.5.5 South and Central America Influenza Vaccine Market Forecasts and Analysis - By Dosage Form
12.5.6 South and Central America Influenza Vaccine Market Forecasts and Analysis - By Age Group
12.5.7 South and Central America Influenza Vaccine Market Forecasts and Analysis - By Distribution Channel
12.5.8 South and Central America Influenza Vaccine Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Influenza Vaccine Market
12.5.8.1.1 Brazil Influenza Vaccine Market by Type
12.5.8.1.2 Brazil Influenza Vaccine Market by Product Type
12.5.8.1.3 Brazil Influenza Vaccine Market by Dosage Form
12.5.8.1.4 Brazil Influenza Vaccine Market by Age Group
12.5.8.1.5 Brazil Influenza Vaccine Market by Distribution Channel
12.5.8.2 Argentina Influenza Vaccine Market
12.5.8.2.1 Argentina Influenza Vaccine Market by Type
12.5.8.2.2 Argentina Influenza Vaccine Market by Product Type
12.5.8.2.3 Argentina Influenza Vaccine Market by Dosage Form
12.5.8.2.4 Argentina Influenza Vaccine Market by Age Group
12.5.8.2.5 Argentina Influenza Vaccine Market by Distribution Channel
12.5.8.3 Rest of South and Central America Influenza Vaccine Market
12.5.8.3.1 Rest of South and Central America Influenza Vaccine Market by Type
12.5.8.3.2 Rest of South and Central America Influenza Vaccine Market by Product Type
12.5.8.3.3 Rest of South and Central America Influenza Vaccine Market by Dosage Form
12.5.8.3.4 Rest of South and Central America Influenza Vaccine Market by Age Group
12.5.8.3.5 Rest of South and Central America Influenza Vaccine Market by Distribution Channel
13. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INFLUENZA VACCINE MARKET
13.1 North America
13.2 Europe
13.3 Asia-Pacific
13.4 Middle East and Africa
13.5 South and Central America
14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. INFLUENZA VACCINE MARKET, KEY COMPANY PROFILES
15.1. EMERGENT BIOSOLUTIONS
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. F. HOFFMANN-LA ROCHE LTD
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. GAMMA VACCINES PTY LTD.
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. ASTRAZENECA PLC.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. BIODIEM
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. CSL LIMITED
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. GLAXOSMITHKLINE PLC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. MERCK AND CO., INC. (MERCK SHARP AND DOHME CORP.)
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. NOVARTIS AG
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS


* Above given report scope is tentative, and may change during the study process as per the research requirement.
* List of companies provided under ‘Company Profile’ chapter is tentative and may change during the course of the study. This list is customizable as per the client requirements.
* Financial information would be provided only for the public companies.
The List of Companies

1. Emergent BioSolutions
2. F. Hoffmann-La Roche Ltd
3. Gamma Vaccines Pty Ltd.
4. AstraZeneca Plc.
5. Biodiem
6. CSL Limited
7. GlaxoSmithKline Plc.
8. Merck & Co., Inc. (Merck Sharp & Dohme Corp.)
9. Novartis AG
10. Pfizer, Inc.
11. Sanofi Pasteur SA
12. Sinovac Biotech Ltd.
TIPRE00022593
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking